Effects of Glucose Fluctuation Intervention on the Prognosis of Patients With Type 2 Diabetes and Cerebral Infarction
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Type 2 Diabetes and Cerebral Infarction
- Sponsor
- Nanjing University of Traditional Chinese Medicine
- Enrollment
- 104
- Locations
- 1
- Primary Endpoint
- Glucose fluctuation
- Last Updated
- 7 years ago
Overview
Brief Summary
The present randomized control trial sought to establish glucose fluctuation as an important target for management on metabolic index, neurologic function, and quality of life in Type 2 diabetes mellitus (T2DM) patients and cerebral infarction (CI).
Detailed Description
There is a significant association between glycemic fluctuation and the incidence of diabetes macrovascular complications. Therefore, understanding the impact of glycemic fluctuations on diabetic macroangiopathy could be helpful for discovering a strategy of prevention and treatment of macroangiopathy in diabetes. However, previous studies on the glycemic fluctuation in T2DM patients with CI were cross-sectional studies, there has been no prospective intervention study confirming the effects of glucose fluctuation targeted management on the prognosis of T2DM patients following CI. Based on previous fingdings, investigators will assess the effects of glucose fluctuation targeted intervention on metabolic index, neurologic function, and quality of life in T2DM patients and CI.
Investigators
Lou Qingqing
Director of Health Education Department
Nanjing University of Traditional Chinese Medicine
Eligibility Criteria
Inclusion Criteria
- •cerebral infarction within one month, diagnosed by magnetic resonance imaging (MRI) or computed tomography (CT) according to 1995 acute cerebral infarction diagnosis standards promulgated by the Fourth National Cerebrovascular Disease Conference \[1\];
- •having type 2 diabetes mellitus (as defined by the WHO diagnostic criteria in 1999) \[2\];
Exclusion Criteria
- •coexisting acute complications of diabetes including diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar syndrome (HHS), metabolic acidosis;
- •severe comorbid chronic complications of diabetes;
- •active malignancy;
- •subjects with mental illness and communication disorders; 5) those actively participating in other research studies.
Outcomes
Primary Outcomes
Glucose fluctuation
Time Frame: 6 months
Largest amplitude of Glycemic Excursions (LAGE)
Glycemic variability
Time Frame: 6 months
fasting plasma glucose variation coefficient (CV-FPG)
Stroke severity
Time Frame: 6 months
The National Institute of Health Stroke Scale includes the following domains: level of consciousness, sensory, neglect, visual field, gaze, facial palsy, motor arm, motor leg, limb ataxia, language, and dysarthria. Each domain is scored on an ordinal scale ranging from 0 to 2, 0 to 3, or 0 to 4. Item scores are summed to a total score ranging from 0 to 42 (the higher the score, the more severe the stroke).
Secondary Outcomes
- Independent living skills(6 months)
- Disability and health-related quality of life after stroke(6 months)
- Glycemic control(6 months)
- Blood lipids(6 months)